A novel intervention including individualized nutritional recommendations reduces hemoglobin A1c level, medication use, and weight in type 2 diabetes

JMIR Diabetes

Volumn 2, Issue 1, 2017, Pages

  McKenzie, Amy L ^a   Hallberg, Sarah J ^a,b   Creighton, Brent C ^a   Volk, Brittanie M ^a   Link, Theresa M ^a   Abner, Marcy K ^a   Glon, Roberta M ^a   McCarter, James P ^a   Volek, Jeff S ^a   Phinney, Stephen D ^a  

^a Virta Health in San Francisco   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

Hb A1c; Ketosis; Mobile health; Type 2 diabetes; Weight loss

Indexed keywords

EID: 85099495266     PISSN: None     EISSN: 23714379     Source Type: Journal    
DOI: 10.2196/diabetes.6981     Document Type: Article

References (40)

1. Saudek CD. Can diabetes be cured?: potential biological and mechanical approaches. J Am Med Assoc 2009 Apr 15;301(15):1588-1590. [doi: 10.1001/jama.2009.508] [Medline: 19366779]
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 Sep 12;352(9131):837-853. [Medline: 9742976]
3. Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care 2014 Dec;37(12):3188-3195 [FREE Full text] [doi: 10.2337/dc14-0874] [Medline: 25231895]
4. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. J Am Med Assoc 1999 Jun 02;281(21):2005-2012. [Medline: 10359389]
5. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002 Oct 24;347(17):1342-1349. [doi: 10.1056/NEJMcp021106] [Medline: 12397193]
6. Sjöström L, Lindroos A, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004 Dec 23;351(26):2683-2693. [doi: 10.1056/NEJMoa035622] [Medline: 15616203]
7. Vargas-Ruiz AG, Hernández-Rivera G, Herrera MF. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2008 Mar;18(3):288-293. [doi: 10.1007/s11695-007-9310-0] [Medline: 18214631]
8. Bistrian BR, Blackburn GL, Flatt JP, Sizer J, Scrimshaw NS, Sherman M. Nitrogen metabolism and insulin requirements in obese diabetic adults on a protein-sparing modified fast. Diabetes 1976 Jun;25(6):494-504. [Medline: 1278601]
9. Bauman WA, Schwartz E, Rose HG, Eisenstein HN, Johnson DW. Early and long-term effects of acute caloric deprivation in obese diabetic patients. Am J Med 1988 Jul;85(1):38-46. [Medline: 3291612]
10. Wing RR, Blair E, Marcus M, Epstein LH, Harvey J. Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome? Am J Med 1994 Oct;97(4):354-362. [Medline: 7942937]
11. Steven S, Hollingsworth KG, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, et al. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 2016 May;39(5):808-815. [doi: 10.2337/dc15-1942] [Medline: 27002059]
12. Phinney SD, Horton ES, Sims EA, Hanson JS, Danforth E, LaGrange BM. Capacity for moderate exercise in obese subjects after adaptation to a hypocaloric, ketogenic diet. J Clin Invest 1980 Nov;66(5):1152-1161 [FREE Full text] [doi: 10.1172/JCI109945] [Medline: 7000826]
13. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005 Mar 15;142(6):403-411. [Medline: 15767618]
14. Yancy WS, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2005 Dec 01;2:34 [FREE Full text] [doi: 10.1186/1743-7075-2-34] [Medline: 16318637]
15. Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007 Aug;302(1-2):249-256. [doi: 10.1007/s11010-007-9448-z] [Medline: 17447017]
16. Westman EC, Yancy WS, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 2008;5:36 [FREE Full text] [doi: 10.1186/1743-7075-5-36] [Medline: 19099589]
17. Iqbal N, Vetter ML, Moore RH, Chittams JL, Dalton-Bakes CV, Dowd M, et al. Effects of a low-intensity intervention that prescribed a low-carbohydrate vs. a low-fat diet in obese, diabetic participants. Obesity (Silver Spring) 2010 Sep;18(9):1733-1738 [FREE Full text] [doi: 10.1038/oby.2009.460] [Medline: 20019677]
18. Nielsen JV, Joensson EA. Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up. Nutr Metab (Lond) 2008;5:14 [FREE Full text] [doi: 10.1186/1743-7075-5-14] [Medline: 18495047]
19. Saslow LR, Kim S, Daubenmier JJ, Moskowitz JT, Phinney SD, Goldman V, et al. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS One 2014;9(4):e91027 [FREE Full text] [doi: 10.1371/journal.pone.0091027] [Medline: 24717684]
20. Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, et al. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr 2015 Oct;102(4):780-790. [doi: 10.3945/ajcn.115.112581] [Medline: 26224300]
21. Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008 Jan;43(1):65-77. [doi: 10.1007/s11745-007-3132-7] [Medline: 18046594]
22. Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 2009 Apr;44(4):297-309. [doi: 10.1007/s11745-008-3274-2] [Medline: 19082851]
23. Forsythe C, Phinney S, Feinman R, Volk B, Freidenreich D, Quann E, et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 2010 Oct;45(10):947-962 [FREE Full text] [doi: 10.1007/s11745-010-3467-3] [Medline: 20820932]
24. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le MN, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013 Jan 11;339(6116):211-214 [FREE Full text] [doi: 10.1126/science.1227166] [Medline: 23223453]
25. Gumbiner B, Wendel JA, McDermott MP. Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1996 Jan;63(1):110-115. [Medline: 8604657]
26. Newman JC, Verdin E. β-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract 2014 Nov;106(2):173-181 [FREE Full text] [doi: 10.1016/j.diabres.2014.08.009] [Medline: 25193333]
27. Volek JS, Phinney SD. The Art and Science of Low Carbohydrate Living. Florida, USA: Beyond Obesity, LLC; 2011.
28. American Diabetes Association. Standards of medical care in diabetes-2016 abridged for primary care providers. Clin Diabetes 2016 Jan;34(1):3-21 [FREE Full text] [doi: 10.2337/diaclin.34.1.3] [Medline: 26807004]
29. O'Neil P, Miller-Kovach K, Tuerk P, Becker L, Wadden T, Fujioka K, et al. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring) 2016 Nov;24(11):2269-2277. [doi: 10.1002/oby.21616] [Medline: 27804264]
30. Garabedian LF, Ross-Degnan D, Wharam JF. Mobile phone and smartphone technologies for diabetes care and self-management. Curr Diab Rep 2015 Dec;15(12):109. [doi: 10.1007/s11892-015-0680-8] [Medline: 26458380]
31. Arambepola C, Ricci-Cabello I, Manikavasagam P, Roberts N, French D, Farmer A. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res 2016 Apr 19;18(4):e86 [FREE Full text] [doi: 10.2196/jmir.5425] [Medline: 27095386]
32. The DCCT Research Group. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group. Diabetes Care 1988;11(7):567-573. [Medline: 2904881]
33. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care 1993 Jan;16(1):21-31. [Medline: 8422777]
34. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009 Jan 08;360(2):129-139. [doi: 10.1056/NEJMoa0808431] [Medline: 19092145]
35. Drenick EJ, Alvarez LC, Tamasi GC, Brickman AS. Resistance to symptomatic insulin reactions after fasting. J Clin Invest 1972 Oct;51(10):2757-2762 [FREE Full text] [doi: 10.1172/JCI107095] [Medline: 5056667]
36. Cahill G, Aoki T. Alternate Fuel Utilization by Brain. In: Cerebral Metabolism and Neural Function. Baltimore/London: Williams and Wilkins; 1980:234-242.
37. Doucet E, Imbeault P, St-Pierre S, Alméras N, Mauriège P, Richard D, et al. Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up. Int J Obes Relat Metab Disord 2000 Jul;24(7):906-914. [Medline: 10918539]
38. Youm Y, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 2015 Mar;21(3):263-269 [FREE Full text] [doi: 10.1038/nm.3804] [Medline: 25686106]
39. Cawley J, Meyerhoefer C, Biener A, Hammer M, Wintfeld N. Savings in medical expenditures associated with reductions in body mass index among US adults with obesity, by diabetes status. Pharmacoeconomics 2015 Jul;33(7):707-722 [FREE Full text] [doi: 10.1007/s40273-014-0230-2] [Medline: 25381647]
40. Miller ME, Williamson JD, Gerstein HC, Byington RP, Cushman WC, Ginsberg HN, et al. Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial. Diabetes Care 2014;37(3):634-643 [FREE Full text] [doi: 10.2337/dc13-1545] [Medline: 24170759]